​

EBOS Group Limited

NZSE:EBO Stock Report

Market Cap: NZ$8.0b

EBOS Group (EBO) Stock Overview

Engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. More details

EBO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance2/6
Financial Health4/6
Dividends5/6

Rewards

Trading at 22.7% below our estimate of its fair value

Earnings are forecast to grow 11.61% per year

Pays a reliable dividend of 3.12%

Risk Analysis

Has a high level of debt


EBO Community Fair Values

Create Narrative

See what 24 others think this stock is worth. Follow their fair value or set your own to get alerts.

INBS logo
Intelligent Bio Solutions
JO
Jolt_Communications
Community Contributor

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
View narrative
US$2.98
FV
40.3% undervalued intrinsic discount
59.20%
Revenue growth p.a.
9users have liked this narrative
0users have commented on this narrative
55users have followed this narrative
about 1 month ago author updated this narrative
EBO logo
EBOS Group
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts

MedTech Acquisitions And Store Expansion Expected To Drive Future Success

Key Takeaways Strategic acquisitions and pharmacy agreements are set to enhance revenue growth and market share in the healthcare sector. Cost-cutting and sustainability initiatives aim to improve net margins and operational efficiency in the long term.
View narrative
NZ$41.65
FV
5.3% undervalued intrinsic discount
4.10%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
5 days ago author updated this narrative
View EBOS Group Community

EBOS Group Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for EBOS Group
Historical stock prices
Current Share PriceNZ$39.45
52 Week HighNZ$42.55
52 Week LowNZ$32.02
Beta0.26
1 Month Change4.78%
3 Month Change5.28%
1 Year Change20.27%
3 Year Change1.81%
5 Year Change79.32%
Change since IPO1,638.38%

Recent News & Updates

EBOS Group Limited's (NZSE:EBO) Popularity With Investors Is Under Threat From Overpricing

Apr 29
EBOS Group Limited's (NZSE:EBO) Popularity With Investors Is Under Threat From Overpricing

Recent updates

EBOS Group Limited's (NZSE:EBO) Popularity With Investors Is Under Threat From Overpricing

Apr 29
EBOS Group Limited's (NZSE:EBO) Popularity With Investors Is Under Threat From Overpricing

These 4 Measures Indicate That EBOS Group (NZSE:EBO) Is Using Debt Reasonably Well

Mar 30
These 4 Measures Indicate That EBOS Group (NZSE:EBO) Is Using Debt Reasonably Well

Analyst Estimates: Here's What Brokers Think Of EBOS Group Limited (NZSE:EBO) After Its Half-Year Report

Feb 21
Analyst Estimates: Here's What Brokers Think Of EBOS Group Limited (NZSE:EBO) After Its Half-Year Report

Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing

Feb 11
Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing
author-image

New High-Value Products And Expansion Into Southeast Asia Will Create Future Opportunities

Strategic acquisitions and new high-value products in healthcare and animal care promise revenue and earnings growth.

Is There An Opportunity With EBOS Group Limited's (NZSE:EBO) 23% Undervaluation?

Jan 13
Is There An Opportunity With EBOS Group Limited's (NZSE:EBO) 23% Undervaluation?

Risks To Shareholder Returns Are Elevated At These Prices For EBOS Group Limited (NZSE:EBO)

Dec 29
Risks To Shareholder Returns Are Elevated At These Prices For EBOS Group Limited (NZSE:EBO)

The Returns At EBOS Group (NZSE:EBO) Aren't Growing

Nov 11
The Returns At EBOS Group (NZSE:EBO) Aren't Growing

Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now

Oct 16
Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Oct 11
Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Sep 29
Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued

Sep 15
An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued

Earnings Not Telling The Story For EBOS Group Limited (NZSE:EBO)

Jul 27
Earnings Not Telling The Story For EBOS Group Limited (NZSE:EBO)

Shareholder Returns

EBONZ HealthcareNZ Market
7D2.6%3.8%1.5%
1Y20.3%8.6%6.2%

Return vs Industry: EBO exceeded the NZ Healthcare industry which returned 8.6% over the past year.

Return vs Market: EBO exceeded the NZ Market which returned 6.2% over the past year.

Price Volatility

Is EBO's price volatile compared to industry and market?
EBO volatility
EBO Average Weekly Movement3.6%
Healthcare Industry Average Movement5.0%
Market Average Movement5.0%
10% most volatile stocks in NZ Market8.5%
10% least volatile stocks in NZ Market3.0%

Stable Share Price: EBO has not had significant price volatility in the past 3 months compared to the NZ market.

Volatility Over Time: EBO's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19225,200Grant Vineywww.ebosgroup.com

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.

EBOS Group Limited Fundamentals Summary

How do EBOS Group's earnings and revenue compare to its market cap?
EBO fundamental statistics
Market capNZ$8.03b
Earnings (TTM)NZ$266.01m
Revenue (TTM)NZ$13.63b
30.1x
P/E Ratio
0.6x
P/S Ratio

Is EBO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EBO income statement (TTM)
RevenueAU$12.60b
Cost of RevenueAU$10.99b
Gross ProfitAU$1.61b
Other ExpensesAU$1.36b
EarningsAU$245.86m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Aug 26, 2025

Earnings per share (EPS)1.21
Gross Margin12.78%
Net Profit Margin1.95%
Debt/Equity Ratio53.4%

How did EBO perform over the long term?

See historical performance and comparison

Dividends

3.1%
Current Dividend Yield
85%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/07 06:20
End of Day Share Price 2025/07/07 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

EBOS Group Limited is covered by 17 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Saul HadassinBarrenjoey Markets Pty Limited
Benjamin BrayshawBarrenjoey Markets Pty Limited
Lyanne HarrisonBofA Global Research